A Better Newspaper

Developing Story

Musk v. OpenAI – Nonprofit-to-For-Profit Conversion Trial

Elon Musk's lawsuit against OpenAI over its nonprofit-to-for-profit conversion continues, with Musk testifying that Sam Altman 'stole a charity' and calling it 'dangerous' to have an untrustworthy leader in charge of AI development.

Importance: 75%Confidence: 85%Mentions: 1Updated: September 1, 2026
## Overview Elon Musk's lawsuit against OpenAI and CEO Sam Altman over the company's conversion from nonprofit to for-profit status continues to generate significant courtroom testimony. In recent testimony, Musk claimed Altman 'stole a charity,' asserting it is 'dangerous' to have someone 'not trustworthy' in charge of AI (FT). ## Key Details - Musk testified that Altman 'stole a charity' in reference to OpenAI's transition from its nonprofit origins to a for-profit structure (FT). - Musk characterized having an untrustworthy figure in charge of advanced AI development as 'dangerous' (FT). - The trial is examining the legitimacy of OpenAI's corporate restructuring and the original nonprofit mission commitments made to early funders, including Musk. ## Why It Matters This litigation has become one of the most closely watched cases in AI governance, testing whether OpenAI's shift away from nonprofit control breached fiduciary or founding commitments. The outcome could set precedent for how AI labs structure ownership, influence future nonprofit-to-for-profit conversions in tech, and shape public trust in frontier AI governance. For attorneys, it is a key case study in nonprofit conversion law, breach of charitable purpose claims, and corporate governance disputes among founders. ## Developing Angles - Additional witness testimony expected as trial continues, including further statements from Altman. - Potential for settlement, damages, or structural remedies affecting OpenAI's corporate structure. - Spillover effects on OpenAI's IPO plans and investor confidence. - Broader industry implications for AI lab governance structures.